title: [Alterations of urinary excretion of antipyrine metabolites in patients with cirrhosis of the liver].
authors.forename: S
authors.initials: S
authors.lastname: Noda
authors.forename: S
authors.initials: S
authors.lastname: Kawata
authors.forename: N
authors.initials: N
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Miyoshi
authors.forename: Y
authors.initials: Y
authors.lastname: Imai
authors.forename: R
authors.initials: R
authors.lastname: Saitoh
authors.forename: S
authors.initials: S
authors.lastname: Tamura
authors.forename: M
authors.initials: M
authors.lastname: Inada
authors.forename: Y
authors.initials: Y
authors.lastname: Inui
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuda
mesh_terms: D000983:Antipyrine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D006528:Carcinoma, Hepatocellular / Q000150:complications; D000077553:Edaravone; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000652:urine*; D008113:Liver Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged
chemical_list: C007983:4-hydroxyantipyrine; C031820:3-hydroxymethylantipyrine; D000077553:Edaravone; D000983:Antipyrine